BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31006618)

  • 1. Validation and Invalidation of Chemical Probes for the Human N-myristoyltransferases.
    Kallemeijn WW; Lueg GA; Faronato M; Hadavizadeh K; Goya Grocin A; Song OR; Howell M; Calado DP; Tate EW
    Cell Chem Biol; 2019 Jun; 26(6):892-900.e4. PubMed ID: 31006618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents.
    Das U; Kumar S; Dimmock JR; Sharma RK
    Curr Cancer Drug Targets; 2012 Jul; 12(6):667-92. PubMed ID: 22463587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl CoA:protein N-myristoyltransferase.
    Paige LA; Zheng GQ; DeFrees SA; Cassady JM; Geahlen RL
    Biochemistry; 1990 Nov; 29(46):10566-73. PubMed ID: 2271666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the discovery of N-myristoyltransferase inhibitors.
    Zhao C; Ma S
    ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Myristoyltransferase Inhibition Induces ER-Stress, Cell Cycle Arrest, and Apoptosis in Cancer Cells.
    Thinon E; Morales-Sanfrutos J; Mann DJ; Tate EW
    ACS Chem Biol; 2016 Aug; 11(8):2165-76. PubMed ID: 27267252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting N-myristoylation for therapy of B-cell lymphomas.
    Beauchamp E; Yap MC; Iyer A; Perinpanayagam MA; Gamma JM; Vincent KM; Lakshmanan M; Raju A; Tergaonkar V; Tan SY; Lim ST; Dong WF; Postovit LM; Read KD; Gray DW; Wyatt PG; Mackey JR; Berthiaume LG
    Nat Commun; 2020 Oct; 11(1):5348. PubMed ID: 33093447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole Proteome Profiling of
    Goya Grocin A; Serwa RA; Morales Sanfrutos J; Ritzefeld M; Tate EW
    Mol Cell Proteomics; 2019 Jan; 18(1):115-126. PubMed ID: 30341083
    [No Abstract]   [Full Text] [Related]  

  • 8. Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression.
    Kim S; Alsaidan OA; Goodwin O; Li Q; Sulejmani E; Han Z; Bai A; Albers T; Beharry Z; Zheng YG; Norris JS; Szulc ZM; Bielawska A; Lebedyeva I; Pegan SD; Cai H
    Cancer Res; 2017 Dec; 77(24):6950-6962. PubMed ID: 29038344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein N-myristoylation blocks Plasmodium falciparum intraerythrocytic development, egress and invasion.
    Schlott AC; Knuepfer E; Green JL; Hobson P; Borg AJ; Morales-Sanfrutos J; Perrin AJ; Maclachlan C; Collinson LM; Snijders AP; Tate EW; Holder AA
    PLoS Biol; 2021 Oct; 19(10):e3001408. PubMed ID: 34695132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis.
    Ducker CE; Upson JJ; French KJ; Smith CD
    Mol Cancer Res; 2005 Aug; 3(8):463-76. PubMed ID: 16123142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of T cells with 2-hydroxymyristic acid inhibits the myristoylation and alters the stability of p56lck.
    Nadler MJ; Harrison ML; Ashendel CL; Cassady JM; Geahlen RL
    Biochemistry; 1993 Sep; 32(35):9250-5. PubMed ID: 8103677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myristic acid analogs are inhibitors of Junin virus replication.
    Cordo SM; Candurra NA; Damonte EB
    Microbes Infect; 1999 Jul; 1(8):609-14. PubMed ID: 10611737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent.
    Lodge JK; Jackson-Machelski E; Higgins M; McWherter CA; Sikorski JA; Devadas B; Gordon JI
    J Biol Chem; 1998 May; 273(20):12482-91. PubMed ID: 9575206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry.
    Priyamvada L; Kallemeijn WW; Faronato M; Wilkins K; Goldsmith CS; Cotter CA; Ojeda S; Solari R; Moss B; Tate EW; Satheshkumar PS
    PLoS Pathog; 2022 Oct; 18(10):e1010662. PubMed ID: 36215331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of varicella-zoster virus replication by an inhibitor of protein myristoylation.
    Harper DR; Gilbert RL; Blunt C; McIlhinney RA
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1181-4. PubMed ID: 8389801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.
    Duronio RJ; Jackson-Machelski E; Heuckeroth RO; Olins PO; Devine CS; Yonemoto W; Slice LW; Taylor SS; Gordon JI
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1506-10. PubMed ID: 2406721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
    Bell AS; Mills JE; Williams GP; Brannigan JA; Wilkinson AJ; Parkinson T; Leatherbarrow RJ; Tate EW; Holder AA; Smith DF
    PLoS Negl Trop Dis; 2012; 6(4):e1625. PubMed ID: 22545171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes.
    Paape D; Bell AS; Heal WP; Hutton JA; Leatherbarrow RJ; Tate EW; Smith DF
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3363. PubMed ID: 25522361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1.
    French KJ; Zhuang Y; Schrecengost RS; Copper JE; Xia Z; Smith CD
    J Pharmacol Exp Ther; 2004 Apr; 309(1):340-7. PubMed ID: 14724220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.